Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
Authors
Keywords
-
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume -, Issue -, Pages 113522
Publisher
Elsevier BV
Online
2022-08-15
DOI
10.1016/j.biopha.2022.113522
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
- (2022) Wilfredo F. Garcia-Beltran et al. CELL
- SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
- (2022) Wanwisa Dejnirattisai et al. CELL
- Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2
- (2022) Pengcheng Han et al. CELL
- Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron
- (2022) Zhen Cui et al. CELL
- SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination
- (2022) Pengfei Li et al. CELL RESEARCH
- Omicron variant in the current SARS-CoV-2 pandemic
- (2022) Kaveh Nasiri et al. Journal of Dental Sciences
- Emergence of Omicron third lineage BA.3 and its importance
- (2022) Perumal A. Desingu et al. JOURNAL OF MEDICAL VIROLOGY
- Twin combination of Omicron and Delta variants triggering a tsunami wave of ever high surges in COVID‐19 cases: A challenging global threat with a special focus on the Indian subcontinent
- (2022) Ranjan K. Mohapatra et al. JOURNAL OF MEDICAL VIROLOGY
- From Alpha to Omicron SARS‐CoV‐2 variants: What their evolutionary signatures can tell us?
- (2022) Robert Andreata‐Santos et al. JOURNAL OF MEDICAL VIROLOGY
- Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines
- (2022) Yusha Araf et al. JOURNAL OF MEDICAL VIROLOGY
- Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study
- (2022) Nicole Wolter et al. LANCET
- Exploring the Immune-Boosting Functions of Vitamins and Minerals as Nutritional Food Bioactive Compounds: A Comprehensive Review
- (2022) Saikat Mitra et al. MOLECULES
- Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and fusogenicity
- (2022) Bo Meng et al. NATURE
- Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron
- (2022) Juan Manuel Carreño et al. NATURE
- Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
- (2022) Elisabetta Cameroni et al. NATURE
- Immunity against Omicron from breakthrough infection could be a matter of timing
- (2022) Saima May Sidik NATURE
- Omicron’s feeble attack on the lungs could make it less dangerous
- (2022) Max Kozlov NATURE
- Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron
- (2022) Huiping Shuai et al. NATURE
- SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo
- (2022) Kenrie P. Y. Hui et al. NATURE
- Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
- (2022) Sandile Cele et al. NATURE
- Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa
- (2022) Raquel Viana et al. NATURE
- Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
- (2022) Yunlong Cao et al. NATURE
- Vaccines Elicit Highly Conserved Cellular Immunity to SARS-CoV-2 Omicron
- (2022) Jinyan Liu et al. NATURE
- Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
- (2022) Lihong Liu et al. NATURE
- Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines
- (2022) Nick Andrews et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination
- (2022) Rolando Pajon et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein–ACE2 complex
- (2022) Dhiraj Mannar et al. SCIENCE
- Steep Decline in Binding Capability of SARS-CoV-2 Omicron Variant (B.1.1.529) RBD to the Antibodies in Early COVID-19 Convalescent Sera and Inactivated Vaccine Sera
- (2022) Wenhao Zhou et al. Viruses-Basel
- Will the next spillover pandemic be deadlier than the COVID-19?: A wake-up call
- (2022) Om Prakash Choudhary et al. International Journal of Surgery
- Emergence of Omicron sub-variant BA.2: Is it a matter of concern amid the COVID-19 pandemic?-Correspondence
- (2022) Manish Dhawan et al. International Journal of Surgery
- Antibody Response of Combination of BNT162b2 and CoronaVac Platforms of COVID-19 Vaccines against Omicron Variant
- (2022) Ka-Wa Khong et al. Vaccines
- There is nothing exempt from the peril of mutation – The Omicron spike
- (2022) Tapan Behl et al. BIOMEDICINE & PHARMACOTHERAPY
- Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant
- (2022) Maren Schubert et al. BMC Medicine
- SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies
- (2022) Prerna Arora et al. Cell Host & Microbe
- SARS-CoV-2 Omicron spike glycoprotein receptor binding domain exhibits super-binder ability with ACE2 but not convalescent monoclonal antibody
- (2022) Olaposi Omotuyi et al. COMPUTERS IN BIOLOGY AND MEDICINE
- Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic
- (2022) Rekha Khandia et al. ENVIRONMENTAL RESEARCH
- Omicron variant infection and the associated immunological scenario
- (2022) Anirban Goutam Mukherjee et al. IMMUNOBIOLOGY
- Malnutrition and Dietary Habits Alter the Immune System Which May Consequently Influence SARS-CoV-2 Virulence: A Review
- (2022) Ashmika Foolchand et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Transmembrane Protease Serine 2 Proteolytic Cleavage of the SARS-CoV-2 Spike Protein: A Mechanistic Quantum Mechanics/Molecular Mechanics Study to Inspire the Design of New Drugs To Fight the COVID-19 Pandemic
- (2022) Luís M. C. Teixeira et al. Journal of Chemical Information and Modeling
- Assessing the risks associated with the emergence of Florona and possible preventive measures
- (2022) Fahadul Islam et al. JOURNAL OF MEDICAL VIROLOGY
- Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning?
- (2022) Christoph Jung et al. JOURNAL OF VIROLOGY
- Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study
- (2022) Tommy Nyberg et al. LANCET
- Effectiveness of BNT162b2 against COVID-19 in adolescents
- (2022) Annabel A Powell et al. LANCET INFECTIOUS DISEASES
- COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England
- (2022) Freja C M Kirsebom et al. LANCET INFECTIOUS DISEASES
- Selection Analysis Identifies Clusters of Unusual Mutational Changes in Omicron Lineage BA.1 That Likely Impact Spike Function
- (2022) Darren P. Martin et al. MOLECULAR BIOLOGY AND EVOLUTION
- Why call it BA.2.12.1? A guide to the tangled Omicron family
- (2022) Amy Maxmen NATURE
- Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2
- (2022) Olha Puhach et al. NATURE MEDICINE
- Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies
- (2022) Timothée Bruel et al. NATURE MEDICINE
- Unlocking capacities of genomics for the COVID-19 response and future pandemics
- (2022) Sergey Knyazev et al. NATURE METHODS
- Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar
- (2022) Laith J. Abu-Raddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cumulative SARS-CoV-2 mutations and corresponding changes in immunity in an immunocompromised patient indicate viral evolution within the host
- (2022) Sissy Therese Sonnleitner et al. Nature Communications
- Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant
- (2022) Fanglei Zuo et al. Nature Communications
- Florona: An emerging threat posing alarming risks to global public health and possible containment measures
- (2022) Fahadul Islam et al. International Journal of Surgery
- Recombinant SARS-CoV-2 variants XD, XE, and XF: The emergence of recombinant variants requires an urgent call for research – Correspondence
- (2022) Chiranjib Chakraborty et al. International Journal of Surgery
- Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions
- (2022) Manish Dhawan et al. Human Vaccines & Immunotherapeutics
- Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study
- (2022) Alejandro Jara et al. Lancet Global Health
- Mutational Pattern, Impacts and Potential Preventive Strategies of Omicron SARS-CoV-2 Variant Infection
- (2022) Endeshaw Chekol Abebe et al. Infection and Drug Resistance
- Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy
- (2022) Maria Pia Sormani et al. EBioMedicine
- SARS-CoV-2 variants – Evolution, spike protein, and vaccines
- (2022) Kai-Wei K. Chen et al. Biomedical Journal
- Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes
- (2022) Jasmin Quandt et al. Science Immunology
- Understanding the omicron variant (B.1.1.529) of SARS-CoV-2: Mutational impacts, concerns, and the possible solutions
- (2022) Fahadul Islam et al. Annals of Medicine and Surgery
- Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectives
- (2022) AbdulRahman A Saied et al. EMBO Molecular Medicine
- Omicron (BA.1) and sub‐variants (BA.1.1, BA.2, and BA.3) of SARS‐CoV‐2 spike infectivity and pathogenicity: A comparative sequence and structural‐based computational assessment
- (2022) Suresh Kumar et al. JOURNAL OF MEDICAL VIROLOGY
- Omicron subvariants escape antibodies elicited by vaccination and BA.2.2 infection
- (2022) Lin Yao et al. LANCET INFECTIOUS DISEASES
- What Omicron’s BA.4 and BA.5 variants mean for the pandemic
- (2022) Ewen Callaway NATURE
- BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
- (2022) Yunlong Cao et al. NATURE
- Mutational cascade of SARS-CoV-2 leading to evolution and emergence of omicron variant
- (2022) Kanika Bansal et al. VIRUS RESEARCH
- Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine
- (2022) Chaitanya Kurhade et al. Nature Communications
- The recently emerged BA.4 and BA.5 lineages of Omicron and their global health concerns amid the ongoing wave of COVID-19 pandemic – Correspondence
- (2022) Ranjan K. Mohapatra et al. International Journal of Surgery
- Is Omicron the end of pandemic or start of a new innings?
- (2022) Swarnali Das et al. Travel Medicine and Infectious Disease
- Molecular mechanisms involved in pathogenicity of SARS-CoV-2: Immune evasion and implications for therapeutic strategies
- (2022) Hatixhe Latifi-Pupovci BIOMEDICINE & PHARMACOTHERAPY
- Evolution of antibody immunity to SARS-CoV-2
- (2021) Christian Gaebler et al. NATURE
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
- (2021) Jennifer M. Dan et al. SCIENCE
- Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2
- (2021) Saman Saadat et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Want to track pandemic variants faster? Fix the bioinformatics bottleneck
- (2021) Emma B. Hodcroft et al. NATURE
- Scientists call for fully open sharing of coronavirus genome data
- (2021) Richard Van Noorden NATURE
- SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
- (2021) Constantinos Kurt Wibmer et al. NATURE MEDICINE
- Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: A review of current evidence
- (2021) Sayeeda Rahman et al. Expert Review of Clinical Pharmacology
- One million coronavirus sequences: popular genome site hits mega milestone
- (2021) Amy Maxmen NATURE
- Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2
- (2021) Chantal B. F. Vogels et al. PLOS BIOLOGY
- The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets
- (2021) Thomas P. Peacock et al. Nature Microbiology
- Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination
- (2021) Rishi R. Goel et al. Science Immunology
- mRNA vaccine effectiveness against COVID-19-related hospitalisations and deaths in older adults: a cohort study based on data linkage of national health registries in Portugal, February to August 2021
- (2021) Baltazar Nunes et al. Eurosurveillance
- SARS‐CoV‐2 B.1.617 Indian variants: Are electrostatic potential changes responsible for a higher transmission rate?
- (2021) Stefano Pascarella et al. JOURNAL OF MEDICAL VIROLOGY
- Structural Basis of Covalent Inhibitory Mechanism of TMPRSS2-Related Serine Proteases by Camostat
- (2021) Gaohui Sun et al. JOURNAL OF VIROLOGY
- Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
- (2021) Delphine Planas et al. NATURE
- Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
- (2021) Zijun Wang et al. NATURE
- SARS-CoV-2 simulations go exascale to predict dramatic spike opening and cryptic pockets across the proteome
- (2021) Maxwell I. Zimmerman et al. Nature Chemistry
- Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis
- (2021) Angela Choi et al. NATURE MEDICINE
- The biological and clinical significance of emerging SARS-CoV-2 variants
- (2021) Kaiming Tao et al. NATURE REVIEWS GENETICS
- SARS-CoV-2 variants, spike mutations and immune escape
- (2021) William T. Harvey et al. NATURE REVIEWS MICROBIOLOGY
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
- (2021) Jamie Lopez Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants
- (2021) Amarendra Pegu et al. SCIENCE
- Efficacy of Bamlanivimab/Etesevimab and Casirivimab/Imdevimab in Preventing Progression to Severe COVID-19 and Role of Variants of Concern
- (2021) Marco Falcone et al. Infectious Diseases and Therapy
- Genomic surveillance to combat COVID-19: challenges and opportunities
- (2021) Janet D Robishaw et al. Lancet Microbe
- D614G mutation and SARS-CoV-2: impact on S-protein structure, function, infectivity, and immunity
- (2021) Manojit Bhattacharya et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines
- (2021) Mohammad Reza Zinatizadeh et al. BIOMEDICINE & PHARMACOTHERAPY
- The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic
- (2021) Markus Hoffmann et al. CELL
- Structural and functional insights into the spike protein mutations of emerging SARS-CoV-2 variants
- (2021) Deepali Gupta et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The COVID-19 pandemic: viral variants and vaccine efficacy
- (2021) Marco Ciotti et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- Emerging SARS-CoV-2 Variants: Genetic Variability and Clinical Implications
- (2021) Aakriti Dubey et al. CURRENT MICROBIOLOGY
- Antibody Response and Variant Cross-Neutralization After SARS-CoV-2 Breakthrough Infection
- (2021) Timothy A. Bates et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies
- (2021) Saathvik R. Kannan et al. JOURNAL OF AUTOIMMUNITY
- Evidence for a mouse origin of the SARS-CoV-2 Omicron variant
- (2021) Changshuo Wei et al. Journal of Genetics and Genomics
- Effectiveness of a Third Dose of BNT162b2 mRNA Vaccine
- (2021) Yaki Saciuk et al. JOURNAL OF INFECTIOUS DISEASES
- Roles of the polybasic furin cleavage site of spike protein in SARS‐CoV‐2 replication, pathogenesis, and host immune responses and vaccination
- (2021) Md. Golzar Hossain et al. JOURNAL OF MEDICAL VIROLOGY
- Sequence analysis of the emerging SARS‐CoV‐2 variant Omicron in South Africa
- (2021) Lulan Wang et al. JOURNAL OF MEDICAL VIROLOGY
- Omicron and Delta variant of SARS‐CoV‐2: A comparative computational study of spike protein
- (2021) Suresh Kumar et al. JOURNAL OF MEDICAL VIROLOGY
- Characterization of the novel SARS‐CoV‐2 Omicron (B.1.1.529) variant of concern and its global perspective
- (2021) Shailendra K. Saxena et al. JOURNAL OF MEDICAL VIROLOGY
- Omicron variant (B.1.1.529) of SARS‐CoV‐2, a global urgent public health alert!
- (2021) Shou‐Jiang Gao et al. JOURNAL OF MEDICAL VIROLOGY
- Omicron (B.1.1.529 variant of SARS‐CoV‐2); an emerging threat: Current global scenario
- (2021) Ranjan K. Mohapatra et al. JOURNAL OF MEDICAL VIROLOGY
- The electrostatic potential of the Omicron variant spike is higher than in Delta and Delta‐plus variants: A hint to higher transmissibility?
- (2021) Stefano Pascarella et al. JOURNAL OF MEDICAL VIROLOGY
- Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
- (2021) Salim S Abdool Karim et al. LANCET
- Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum
- (2021) Wanwisa Dejnirattisai et al. LANCET
- Heavily mutated Omicron variant puts scientists on alert
- (2021) Ewen Callaway NATURE
- Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
- (2021) Koen B. Pouwels et al. NATURE MEDICINE
- Mechanisms of SARS-CoV-2 entry into cells
- (2021) Cody B. Jackson et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa
- (2021) Shirley Collie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection
- (2021) Ital Nemet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasma Neutralization of the SARS-CoV-2 Omicron Variant
- (2021) Fabian Schmidt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar
- (2021) Hiam Chemaitelly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Investigating the aggressiveness of the COVID-19 Omicron variant and suggestions for possible treatment options
- (2021) Md Mohiuddin et al. RESPIRATORY MEDICINE
- Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses
- (2021) Judith M. White et al. mBio
- Emergence and spread of SARS-CoV-2 lineage B.1.620 with variant of concern-like mutations and deletions
- (2021) Gytis Dudas et al. Nature Communications
- Omicron variant (B.1.1.529) of SARS-CoV-2: Threat assessment and plan of action
- (2021) Om Prakash Choudhary et al. International Journal of Surgery
- Omicron SARS-CoV-2 variant: Reasons of emergence and lessons learnt
- (2021) Manish Dhawan et al. International Journal of Surgery
- Convalescent plasma therapy against the emerging SARS-CoV-2 variants: Delineation of the potentialities and risks
- (2021) Manish Dhawan et al. International Journal of Surgery
- The emergence of new SARS-CoV-2 variant (Omicron) and increasing calls for COVID-19 vaccine boosters-The debate continues
- (2021) Naushad Ahmad Khan et al. Travel Medicine and Infectious Disease
- Covid-19: Early studies give hope omicron is milder than other variants
- (2021) Bryan Christie BMJ-British Medical Journal
- Covid-19: Doctors will refuse to limit use of antiviral drug to unvaccinated patients, say ethicists
- (2021) Owen Dyer BMJ-British Medical Journal
- Covid-19: UK approves monoclonal antibody sotrovimab for over 12s at high risk
- (2021) Elisabeth Mahase BMJ-British Medical Journal
- Covid-19: Omicron is causing more infections but fewer hospital admissions than delta, South African data show
- (2021) Owen Dyer BMJ-British Medical Journal
- SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells
- (2021) Hanjun Zhao et al. Emerging Microbes & Infections
- Omicron: a drug developer’s perspective
- (2021) Fang “Flora” Fang et al. Emerging Microbes & Infections
- Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost
- (2021) Jingwen Ai et al. Emerging Microbes & Infections
- Omicron variant and booster COVID-19 vaccines
- (2021) Talha Khan Burki Lancet Respiratory Medicine
- Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity?
- (2021) Gregory Milne et al. Lancet Respiratory Medicine
- D614G mutation eventuates in all VOI and VOC in SARS-CoV-2: Is it part of the positive selection pioneered by Darwin?
- (2021) Chiranjib Chakraborty et al. Molecular Therapy-Nucleic Acids
- Emerging SARS-CoV-2 variants expand species tropism to murines
- (2021) Huiping Shuai et al. EBioMedicine
- Omicron variant of the SARS-CoV-2: a quest to define the consequences of its high mutational load
- (2021) Jorge Quarleri et al. GeroScience
- How to translate the knowledge of COVID‐19 into the prevention of Omicron variants
- (2021) Xiangdong Wang et al. Clinical and Translational Medicine
- Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
- (2020) Michael Letko et al. Nature Microbiology
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Ethics of instantaneous contact tracing using mobile phone apps in the control of the COVID-19 pandemic
- (2020) Michael J Parker et al. JOURNAL OF MEDICAL ETHICS
- COVID-19 Contact Tracing and Data Protection Can Go Together
- (2020) Johannes Abeler et al. JMIR mHealth and uHealth
- Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding
- (2020) Tyler N. Starr et al. CELL
- The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
- (2020) Qianqian Li et al. CELL
- Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
- (2020) Bette Korber et al. CELL
- Immune-boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids: could they help against COVID-19?
- (2020) Hira Shakoor et al. MATURITAS
- Next generation sequencing of SARS-CoV-2 genomes: challenges, applications and opportunities
- (2020) Matteo Chiara et al. BRIEFINGS IN BIOINFORMATICS
- Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
- (2020) Allison J. Greaney et al. Cell Host & Microbe
- Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer
- (2020) Teresa Aydillo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Unraveling the causes of adaptive benefits of synonymous mutations in TEM-1 β-lactamase
- (2018) Mark P. Zwart et al. HEREDITY
- The anti-Shine–Dalgarno sequence drives translational pausing and codon choice in bacteria
- (2012) Gene-Wei Li et al. NATURE
- Synonymous but not the same: the causes and consequences of codon bias
- (2010) Joshua B. Plotkin et al. NATURE REVIEWS GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now